Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Thiourea compounds affect hair growth and pigmentation in black rats.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A new compound that could treat various androgen-related conditions was created and analyzed.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

γ‐Oryzanol ointment increases sebaceous gland activity and sebum production.

Targeting ornithine decarboxylase can help prevent skin cancer.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Minoxidil can cause hair growth as a side effect.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Made 8 minoxidil samples; 1 cocrystal, 7 salts formed.

SH-340 may improve skin barrier and help treat atopic dermatitis.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Scientists found new, better-working inhibitors for a hormone-related enzyme.